Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.41 |
| ▸ | MAPT | P10636 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.41 |
| ▸ | MME | P08473 | 5/20 | 0.39 |
| ▸ | EGLN1 | Q9GZT9 | 2/20 | 0.38 |
| ▸ | ITGB1 | P05556 | 1/20 | 0.37 |
| ▸ | ITGA5 | P08648 | 1/20 | 0.37 |
| ▸ | FAAH | O00519 | 5/20 | 0.36 |
| ▸ | ACE | P12821 | 2/20 | 0.35 |
| ▸ | CPA1 | P15085 | 1/20 | 0.35 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.35 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.35 |
| ▸ | CTH | P32929 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 2/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | USP2 | O75604 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1493216 | 1.00 | ALDH1A1 (0.41) | ALDH1A1MAPTTDP1LMNAPTGS2 | |
| SCHEMBL14417106 | 1.00 | ALDH1A1 (0.41) | ALDH1A1MAPTTDP1LMNAPTGS2 | |
| Mertiatide SCHEMBL23522195 | 0.98 | ALDH1A1 (0.40) | ALDH1A1MAPTTDP1LMNAPTGS2 | |
| SCHEMBL2796838 | 0.98 | ALDH1A1 (0.40) | ALDH1A1MAPTTDP1LMNAPTGS2 | |
| Mertiatide SCHEMBL1650428 | 0.95 | ALDH1A1 (0.39) | ALDH1A1MAPTTDP1LMNAPTGS2 | |
| SCHEMBL75812 | 0.95 | — | — | |
| SCHEMBL12762758 | 0.88 | ALDH1A1 (0.34) | ALDH1A1MAPTTDP1LMNAPTGS2 | |
| Glycine SCHEMBL4653213 | 0.86 | GLRA1 (0.46) | ALDH1A1MAPTTDP1LMNAPTGS2 | |
| Glycine SCHEMBL4264488 | 0.86 | GLRA1 (0.46) | ALDH1A1MAPTTDP1LMNAPTGS2 | |
| SCHEMBL610938 | 0.84 | ALDH1A1 (0.38) | ALDH1A1MAPTTDP1LMNAPTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 2509 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2026105128-A1 | MESO-2,3-DIMERCAPTOSUCCINIC ACID (DMSA)-CONJUGATED NUCLEOTIDE-BASED AGENTS HAVING IMPROVED DELIVERY TO KIDNEY TISSUE | Sheba Impact Ltd. (IL) | 2026-05-21 | — | — | WO | claimed |
| CN-121045338-B | Cyclic peptide targeting CAIX and preparation method and application thereof | 原子高科股份有限公司 | 2026-05-19 | — | — | CN | claimed |
| WO-2026098441-A1 | COMPOSITION AND METHOD FOR CANCER TREATMENT USING POLYPEPTIDE CONJUGATES | SUZHOU SMARTNUCLIDE BIOPHARMACEUTICAL CO., LTD. (CN) | 2026-05-15 | — | — | WO | claimed |
| EP-4705295-A2 | MULTIFUNCTIONAL COMPOUND CORE FOR ACTIVE AGENTS AND USES THEREOF | The University of North Carolina at Chapel Hill (US) | 2026-03-11 | — | — | EP | claimed |
| EP-4444709-B1 | FAP-ALPHA SPECIFIC TUMOR DIAGNOSTIC IMAGING AGENT | JIAXING PHARMADAX GENESIS PHARMACEUTICAL TECH CO LTD (CN) | 2026-02-25 | — | — | EP | claimed |
| US-20260048156-A1 | FAP-TARGETING PHARMACEUTICAL PRODUCT FOR THERAPY AND DIAGNOSIS OF CANCERS | Atoms for Cure GmbH (DE) | 2026-02-19 | — | — | US | claimed |
| US-12514937-B2 | Methods for detecting CCR2 receptors | WASHINGTON UNIVERSITY (US) | 2026-01-06 | — | — | US | claimed |
| EP-4667019-A1 | PSMA-TARGETED RADIOPHARMACEUTICAL, AND SYNTHESIS AND USE THEREOF | Norroy Bioscience Co., Ltd. (CN) | 2025-12-24 | — | — | EP | claimed |
| EP-4661577-A1 | WIRELESS COMMUNICATION METHOD, TERMINAL DEVICE, AND NETWORK DEVICE | GUANGDONG OPPO MOBILE TELECOMMUNICATIONS CORP., LTD. (CN) | 2025-12-10 | — | — | EP | claimed |
| EP-4642489-A1 | CONJUGATE AND USES THEREOF | Full-Life Technologies HK Limited (HK) | 2025-11-05 | — | — | EP | claimed |
| WO-1995013832-A1 | IMMOBILIZED LABELLING METHOD | RESOLUTION PHARMACEUTICALS INC. (CA) | 1995-05-26 | — | — | WO | claimed |
| EP-0483704-B1 | Process for preparing a radiopharmaceutical composition | NIHON MEDIPHYSICS CO LTD (JP) | 1995-04-26 | — | — | EP | claimed |
| WO-1995009564-A1 | COMPOSITIONS AND METHODS FOR MAGNETIC RESONANCE IMAGING, X-RAY IMAGING AND RADIOPHARMACEUTICALS | MALLINCKRODT MEDICAL, INC. (US) | 1995-04-13 | — | — | WO | claimed |
| WO-1994028940-A1 | BLOOD POOL IMAGING COMPOSITION AND METHOD OF ITS USE | THE GENERAL HOSPITAL CORPORATION (US) | 1994-12-22 | — | — | WO | claimed |
| EP-0427360-B1 | Kit (non-radioactive precursor) for the preparation of an enantiomeric form of a liver function diagnostic technetium-99m-mercaptoacetyltriglycine (99m-Tc-MAG-3) and process for the production of the kit | VEREIN FUER KERNVERFAHRENSTECH (DE) | 1994-06-15 | — | — | EP | claimed |
| US-5262175-A | Containing technetium by addition of an oxidizing agent | SOLANKI KISHOR K (GB) | 1993-11-16 | — | — | US | claimed |
| US-5245018-A | Reaction of pertechnetate and a mercaptoacetyltripeptide, kidney diagnosis | NIHON MEDI-PHYSICS CO., LTD. (JP) | 1993-09-14 | — | — | US | claimed |
| EP-0313712-B1 | STABLE RADIODIAGNOSTIC COMPOSITONS AND THEIR PREPARATION | SORIN BIOMEDICA S.p.A. (IT) | 1992-07-29 | — | — | EP | claimed |
| EP-0483704-A1 | Process for preparing a radiopharmaceutical composition | NIHON MEDI-PHYSICS CO., LTD. (JP) | 1992-05-06 | — | — | EP | claimed |
| US-4857299-A | Stable radiodiagnostic product | SOLCO BASEL AG (CH) | 1989-08-15 | — | — | US | claimed |